These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3095802)

  • 1. The ejaculatory behavior of sexually sluggish male rats treated with (-)deprenyl, apomorphine, bromocriptine and amphetamine.
    Dalló J; Lekka N; Knoll J
    Pol J Pharmacol Pharm; 1986; 38(3):251-5. PubMed ID: 3095802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aphrodisiac effect of low doses of (-) deprenyl in male rats.
    Yen TT; Dalló J; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(5-6):303-8. PubMed ID: 6821215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of deprenyl in aged rats.
    Drago F; Continella G; Spadaro F; Cavaliere S; Scapagnini U
    Funct Neurol; 1986; 1(2):165-74. PubMed ID: 3111946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apomorphine, deprenyl, and yohimbine fail to increase sexual behavior in rhesus males.
    Chambers KC; Phoenix CH
    Behav Neurosci; 1989 Aug; 103(4):816-23. PubMed ID: 2504225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting, true aphrodisiac effect of (-)-deprenyl in sexually sluggish old male rats.
    Knoll J; Yen TT; Dallo J
    Mod Probl Pharmacopsychiatry; 1983; 19():135-53. PubMed ID: 6408404
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of (-) deprenyl (selegiline) on different behavioral changes induced by dopamine agonists in the rat.
    Timar J; Knoll B; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):659-66. PubMed ID: 2908366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aphrodisiac effect of (-)deprenyl in male rats.
    Dalló J; Yen TT; Knoll J
    Acta Physiol Hung; 1990; 75 Suppl():75-6. PubMed ID: 2115238
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
    Timar J; Knoll B; Knoll J
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):255-66. PubMed ID: 3103558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual differences in male rat ejaculatory behaviour: searching for models to study ejaculation disorders.
    Pattij T; de Jong TR; Uitterdijk A; Waldinger MD; Veening JG; Cools AR; van der Graaf PH; Olivier B
    Eur J Neurosci; 2005 Aug; 22(3):724-34. PubMed ID: 16101754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Eurycoma longifolia on the copulatory activity of sexually sluggish and impotent male rats.
    Zanoli P; Zavatti M; Montanari C; Baraldi M
    J Ethnopharmacol; 2009 Nov; 126(2):308-13. PubMed ID: 19703544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dinh lang and (-)deprenyl on the survival rate of male rats.
    Yen TT; Dalló J; Knoll J
    Acta Physiol Hung; 1990; 75 Suppl():301-2. PubMed ID: 2115236
    [No Abstract]   [Full Text] [Related]  

  • 12. Aphrodisiac effect of L-DOPA and apomorphine in male sexually sluggish rats.
    Tagliamonte A; Fratta W; Gessa GL
    Experientia; 1974 Apr; 30(4):381-2. PubMed ID: 4837624
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of apomorphine, (+)-amphetamine, and nialamide on tetrabenazine-induced suppression of sexual behavior in the male rat.
    Butcher LL; Butcher SG; Larsson K
    Eur J Pharmacol; 1969 Sep; 7(3):283-8. PubMed ID: 5351986
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the dependence capacity of amphetamine, MK-306 and (-)deprenyl.
    Yasar S; Timár J; Knoll B; Knoll J
    Acta Physiol Hung; 1990; 75 Suppl():299-300. PubMed ID: 2115235
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
    Gessa GL; Tagliamonte A
    Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effects of (-)deprenyl, 1-phenyl-2-propyl-aminopentane (MK-306) and amphetamine on the striatal and limbic dopaminergic system.
    Timár J; Yasar S; Knoll B; Knoll J
    Acta Physiol Hung; 1990; 75 Suppl():279-80. PubMed ID: 2115233
    [No Abstract]   [Full Text] [Related]  

  • 17. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.
    Yasar S; Schindler CW; Thorndike EB; Szelenyi I; Goldberg SR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):1-6. PubMed ID: 8473997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities for behavior correction in a learned ethanol preference in female and male white rats].
    Andronova LM
    Farmakol Toksikol; 1987; 50(4):55-60. PubMed ID: 3666118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human growth hormone and dopaminergic drugs, with special reference to deprenyl (selegiline): a summary of studies on volunteers.
    Koulu M; Lammintausta R
    Acta Neurol Scand Suppl; 1983; 95():91-4. PubMed ID: 6428151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.